Rituxan Hycela
| Rituxan Hycela | |
|---|---|
| Term | Rituxan Hycela |
| Short definition | Rituxan Hycela - (pronounced) (rih-TUK-sun hy-SEL-uh) combination of rituximab and hyaluronidase used to treat adults with certain types of follicular lymphoma, diffuse large B-cell lymphoma, or chronic lymphocytic leukemia. Rituximab attaches to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Rituxan Hycela - (pronounced) (rih-TUK-sun hy-SEL-uh) combination of rituximab and hyaluronidase used to treat adults with certain types of follicular lymphoma, diffuse large B-cell lymphoma, or chronic lymphocytic leukemia. Rituximab attaches to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells. This can help the immune system kill cancer cells. Hyaluronidase allows rituximab to be injected under the skin. Rituxan Hycela can be given in less time than rituximab alone, which is given as an infusion. Also called rituximab and hyaluronidase
External links
- Medical encyclopedia article on Rituxan Hycela
- Wikipedia's article - Rituxan Hycela
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski